Peter Kaufman - Dissemin

All papers authored by Peter Kaufman

This paper was not found in any repository, but could be made available legally by the author.

2024 Ravi K. Goyal

, Jingchuan Zhang, Keith L. Davis, Martina Sluga-O’Callaghan, Peter A. Kaufman

Real-world treatment patterns and clinical outcomes in patients treated with eribulin after prior phosphoinositide 3-Kinase inhibitor treatment for metastatic breast cancer

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

2023 Xu Cao, Kristen E. Muller, Mary D. Chamberlin, Jiang Gui, Peter A. Kaufman

, Gary N. Schwartz, Roberta M. diFlorio Alexander, Brian W. Pogue, Keith D. Paulsen, Shudong Jiang

Data from Near-Infrared Spectral Tomography for Predicting Residual Cancer Burden during Early-Stage Neoadjuvant Chemotherapy for Breast Cancer

Upload

Xu Cao, Kristen E. Muller, Mary D. Chamberlin, Jiang Gui, Peter A. Kaufman

, Gary N. Schwartz, Roberta M. diFlorio Alexander, Brian W. Pogue, Keith D. Paulsen, Shudong Jiang

Table S1,Table S2 from Near-Infrared Spectral Tomography for Predicting Residual Cancer Burden during Early-Stage Neoadjuvant Chemotherapy for Breast Cancer

Upload

Matthew P. Goetz

, Erika P. Hamilton

, Mario Campone

, Sara A. Hurvitz

, Javier Cortes

, Stephen Johnston

, Antonio Llombart-Cussac

, Peter A. Kaufman

, Masakazu Toi

, Guy Jerusalem

, Hillary Graham

, Hong Wang

, Valerie M. Jansen

, Lacey M. Litchfield

, Miguel Martin

Landscape of Baseline and Acquired Genomic Alterations in Circulating Tumor DNA with Abemaciclib Alone or with Endocrine Therapy in Advanced Breast Cancer

Upload

This paper is made freely available by the publisher.

Sara M. Tolaney

, Arlene Chan

, Katarina Petrakova, Suzette Delaloge

, Mario Campone, Hiroji Iwata

, Parvin F. Peddi

, Peter A. Kaufman

, Elisabeth De Kermadec, Qianying Liu, Patrick Cohen

, Gautier Paux

, Lei Wang, Nils Ternès, Eric Boitier and 1 other authors

AMEERA-3: Randomized Phase II Study of Amcenestrant (Oral Selective Estrogen Receptor Degrader) Versus Standard Endocrine Monotherapy in Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer

Download from doi.org

Gary N. Schwartz, Peter A. Kaufman

, Karthik V. Giridhar, Jonathan D. Marotti, Mary D. Chamberlin, Bradley A. Arrick, Grace Makari-Judson, Matthew P. Goetz, Shannon M. Soucy, Fred Kolling, Eugene Demidenko, Todd W. Miller

Data from Alternating 17β-Estradiol and Aromatase Inhibitor Therapies Is Efficacious in Postmenopausal Women with Advanced Endocrine-Resistant ER⁺ Breast Cancer

Upload

Gary N. Schwartz, Peter A. Kaufman

, Karthik V. Giridhar, Jonathan D. Marotti, Mary D. Chamberlin, Bradley A. Arrick, Grace Makari-Judson, Matthew P. Goetz, Shannon M. Soucy, Fred Kolling, Eugene Demidenko, Todd W. Miller

Supplementary Methods 1 from Alternating 17β-Estradiol and Aromatase Inhibitor Therapies Is Efficacious in Postmenopausal Women with Advanced Endocrine-Resistant ER⁺ Breast Cancer

Upload

Gary N. Schwartz, Peter A. Kaufman

, Karthik V. Giridhar, Jonathan D. Marotti, Mary D. Chamberlin, Bradley A. Arrick, Grace Makari-Judson, Matthew P. Goetz, Shannon M. Soucy, Fred Kolling, Eugene Demidenko, Todd W. Miller

Supplementary Tables 1-8 from Alternating 17β-Estradiol and Aromatase Inhibitor Therapies Is Efficacious in Postmenopausal Women with Advanced Endocrine-Resistant ER⁺ Breast Cancer

Upload

Gary N. Schwartz, Peter A. Kaufman

, Karthik V. Giridhar, Jonathan D. Marotti, Mary D. Chamberlin, Bradley A. Arrick, Grace Makari-Judson, Matthew P. Goetz, Shannon M. Soucy, Fred Kolling, Eugene Demidenko, Todd W. Miller

Supplementary Fig. 1 from Alternating 17β-Estradiol and Aromatase Inhibitor Therapies Is Efficacious in Postmenopausal Women with Advanced Endocrine-Resistant ER⁺ Breast Cancer

Upload

2021 Peter A. Kaufman

, Sara A. Hurvitz, Joyce O’Shaughnessy, Ginny Mason, Denise A. Yardley, Adam M. Brufsky, Hope S. Rugo, Melody Cobleigh, Sandra M. Swain, Debu Tripathy, Anne Morris, Vincent Antao, Haocheng Li, Mohammad Jahanzeb

Baseline characteristics and first-line treatment patterns in patients with HER2-positive metastatic breast cancer in the SystHERs registry

Upload

Missing publications? Search for publications with a matching author name.

Researcher

Statistics

Refine

All papers authored by Peter Kaufman